Literature DB >> 4413316

Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys.

R T Harris, W Waters, D McLendon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4413316     DOI： 10.1007/BF00426679

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  4 in total

1.  Injectible dispersion of delta 9-tetrahydrocannabinol in saline using polyvinylpyrrolidone.

Authors:  D C Fenimore; P R Loy
Journal:  J Pharm Pharmacol       Date:  1971-04       Impact factor: 3.765

2.  Effects of (--)delta-9-trans-tetrahydrocannabinol in man.

Authors:  H Isbell; C W Gorodetzsky; D Jasinski; U Claussen; F von Spulak; F Korte
Journal:  Psychopharmacologia       Date:  1967

3.  A comparison of pentobarbital and cocaine self-administration in rhesus monkeys: effects of dose and fixed-ratio parameter.

Authors:  S R Goldberg; F Hoffmeister; U U Schlichting; W Wuttke
Journal:  J Pharmacol Exp Ther       Date:  1971-11       Impact factor: 4.030

4.  Self-administration of psychoactive substances by the monkey.

Authors:  G Deneau; T Yanagita; M H Seevers
Journal:  Psychopharmacologia       Date:  1969
  4 in total
  32 in total

1.  Precipitated Δ9-THC withdrawal reduces motivation for sucrose reinforcement in mice.

Authors:  M L Eckard; K R Trexler; B T Kotson; K G Anderson; S G Kinsey
Journal:  Pharmacol Biochem Behav       Date:  2020-06-09       Impact factor: 3.533

Review 2.  Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Authors:  William E Fantegrossi; Jeffery H Moran; Anna Radominska-Pandya; Paul L Prather
Journal:  Life Sci       Date:  2013-09-29       Impact factor: 5.037

Review 3.  Synthetic Pot: Not Your Grandfather's Marijuana.

Authors:  Benjamin M Ford; Sherrica Tai; William E Fantegrossi; Paul L Prather
Journal:  Trends Pharmacol Sci       Date:  2017-02-02       Impact factor: 14.819

4.  Effect of footshock stress on place conditioning produced by Δ9-tetrahydrocannabinol and the fatty acid amide hydrolase (FAAH) inhibitor, URB597, in Sprague-Dawley rats.

Authors:  Marieka V DeVuono; Kiri L Wills; Danielle V MacPherson; Kelly M Hrelja; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2017-08-12       Impact factor: 4.530

5.  Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction.

Authors:  M Mas-Nieto; B Pommier; E T Tzavara; A Caneparo; S Da Nascimento; G Le Fur; B P Roques; F Noble
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 6.  Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.

Authors:  Leigh V Panlilio; Zuzana Justinova
Journal:  Neuropsychopharmacology       Date:  2017-08-28       Impact factor: 7.853

7.  Naloxone-induced or postwithdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant rats.

Authors:  S Kaymakçalan; I H Ayhan; F C Tulunay
Journal:  Psychopharmacology (Berl)       Date:  1977-12-28       Impact factor: 4.530

8.  Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.

Authors:  Jennifer L Stewart; Lance R McMahon
Journal:  J Pharmacol Exp Ther       Date:  2010-04-07       Impact factor: 4.030

9.  An abstinence syndrome following chronic administration of delta-9-terahydrocannabinol in rhesus monkeys.

Authors:  A B Fredericks; N L Benowitz
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

Review 10.  Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.

Authors:  Ziva D Cooper; Margaret Haney
Journal:  Addict Biol       Date:  2008-02-14       Impact factor: 4.280
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.